Abstract Pituitary adenylate cyclase activating polypeptide (PACAP) is a potent vasodilator of numerous vascular beds, including cerebral arteries. Although PACAP-induced cerebral artery dilation is suggested to be cyclic AMP (cAMP)-dependent, the downstream intracellular signaling pathways are still not fully understood. In this study, we examined the role of smooth muscle K + channels and hypothesized that PACAP-mediated increases in cAMP levels and protein kinase A (PKA) activity result in the coordinate activation of ATP-sensitive K + (K ATP ) and large-conductance Ca
Introduction
Pituitary adenylate cyclase activating polypeptide (PACAP) is a peptide that is highly conserved over species and widely distributed in the brain and peripheral organs. While acting as a neurotransmitter and neurotrophic peptide in the central and peripheral nervous systems (reviewed in Vaudry et al. 2009 ), PACAP is also a potent vasodilator (Warren et al. 1992; Vaudry et al. 2009; Syed et al. 2012) . PACAP-induced vasodilation has been observed in various vascular beds including coronary arteries (Bruch et al. 1997; Dalsgaard et al. 2003) , pulmonary arteries (Cheng et al. 1993) , mesenteric arteries (Wilson and Warren 1993) , and cerebral arteries (Tong et al. 1993; Anzai et al. 1995) . For example, in vivo treatment of PACAP via an open cranial window resulted in brain pial artery dilation in newborn pigs (Tong et al. 1993 ) and intracisternal administration of PACAP caused dose-dependent canine basilar artery dilation detected by angiography (Seki et al. 1995) . Further, in ex vivo studies, PACAP caused concentration-dependent relaxation of isolated canine basilar arteries (Anzai et al. 1995; Seki et al. 1995) , cat cerebral arteries (Uddman et al. 1993) , rabbit posterior cerebral arteries (Dalsgaard et al. 2003) , rat middle cerebral arteries (Erdling et al. 2013) , and rat intracerebral arterioles (Anzai et al. 1995) . This vasodilatory effect is, at least in part, a direct effect of PACAP on arterial smooth muscle cells. PACAP has been identified in the perivascular innervation of human cerebral arteries, which may represent the source of PACAP interacting with cerebral artery myocytes (Eftekhari et al. 2013) . PACAP binds to three types of receptors: PAC1, VPAC1, and VPAC2 (Vaudry et al. 2009; Harmar et al. 2012) , and all three receptors are expressed in cerebral artery smooth muscle cells (Syed et al. 2012; Erdling et al. 2013) . Binding of PACAP to PACAP receptors increases production of adenosine 3′, 5′-cyclic monophosphate (cAMP) (Tong et al. 1993; Vaudry et al. 2009 ) in arterial myocytes which likely accounts for the mechanism of PACAP-induced cerebral artery dilation.
Increased cAMP production and subsequent activation of cAMP-dependent protein kinase (protein kinase A, PKA) can produce vasodilation by several mechanisms including activation of smooth muscle K + channels (Nelson and Quayle 1995; Wellman et al. 1998) . Potassium channels play an important role in the regulation of smooth muscle membrane potential, intracellular Ca 2+ concentration, and arterial diameter; activation of smooth muscle K + channels causes membrane potential hyperpolarization, decreased open-state probability of voltage-dependent Ca 2+ channels, and reduced intracellular Ca 2+ concentration resulting in vasodilation (Standen et al. 1989; Nelson and Quayle 1995; Standen and Quayle 1998) . Dilations induced by a number of endogenous vasoactive substances such as calcitonin gene-related peptide (CGRP) have been shown to result from increased ATPsensitive K + (K ATP ) channel currents via mechanisms involving adenylyl cyclase activation, increased cAMP production, and PKA activation (Nelson et al. 1990; Quayle et al. 1994; Kleppisch and Nelson 1995a; Wellman et al. 1998) . Similarly, K ATP channel blockers were able to partially inhibit PACAPinduced vasodilation in coronary and pulmonary arteries, suggesting that PACAP may also activate K ATP channels (Bruch et al. 1997 (Bruch et al. , 1998 increases resulting from the opening of a small cluster of ryanodine-sensitive Ca 2+ channels (ryanodine receptors, RyRs) located on the sarcoplasmic reticulum (SR). These localized increases in intracellular Ca 2+ lead to activation of nearby BK channels on the plasma membrane (transient outward BK currents), resulting in smooth muscle membrane potential hyperpolarization and vasodilation (Nelson et al. 1995; Wellman and Nelson 2003) . Considering that the treatment of cerebral artery myocytes with cAMP analogs or adenylyl cyclase activators (to elevate intracellular cAMP levels) can increase the frequency and amplitude of transient outward BK currents (Porter et al. 1998; Wellman et al. 2001; Hayoz et al. 2007) , we hypothesized that PACAP-induced increases in cAMP can also activate the Ca 2+ spark/transient outward BK current pathway to promote cerebral vasodilation.
Because of its vasodilatory, neurotrophic, and neuroprotective effects, PACAP has been examined in animal models as possible treatments for cerebral vasospasm after subarachnoid hemorrhage (Kaminuma et al. 1998 ) and ischemic stroke (Reglodi et al. 2000; Ohtaki et al. 2006) . However, despite its therapeutic potential, the detailed intracellular signaling mechanisms involved in PACAP-induced cerebral artery dilation are not fully understood. In this study, we have examined the vasodilatory mechanisms of PACAP, focusing specifically on the role of smooth muscle K + channels in freshly isolated rat superior cerebellar arteries. Our results indicate that activation of both K ATP and BK channels contribute to PACAP-induced cerebral artery dilation.
Methods

Measurements of K ATP Currents and Transient Outward BK Currents
All experiments and protocols were performed in accordance with the Guide for the care and use of laboratory animals (eighth edition, 2011) and were approved by the Institutional Animal Care Committee of the University of Vermont. Male Sprague-Dawley rats (300-350 g; Charles River Laboratories, Saint Constant, QC, Canada) were euthanized by decapitation under deep pentobarbital anesthesia. The brain was carefully removed and superior cerebellar arteries were isolated in icecold artificial cerebrospinal fluid (aCSF; 125 mM NaCl, 3 mM KCl, 18 mM NaHCO 3 , 1.25 mM NaH 2 PO 4 , 1 mM MgCl 2 , 2 mM CaCl 2 , and 5 mM glucose, aerated with 5 % CO 2 , 20 % O 2 , 75 % N 2 , pH 7.35-7.40).
Arterial myocytes were enzymatically isolated using a previously described protocol (Ishiguro et al. 2005; Koide et al. 2007 Koide et al. , 2011 . Briefly, arteries were incubated in a solution containing papain (0.3 mg/mL papain, 0.7 mg/mL 1,4-dithioerythriol) for 17 min at 37°C and then in collagenase solution (0.7 mg/mL collagenase type F, 0.3 mg/mL collagenase type H, 0.1 mM CaCl 2 ) for 20 min at 37°C. Enzyme solutions were made using a glutamate-containing isolation solution (GIS; 55 mM NaCl, 5.6 mM KCl, 80 mML-glutamic acid-Na, 2 mM MgCl 2 , 10 mM HEPES, and 10 mM glucose; pH 7.3). Finally, arteries were washed three times (10 min each wash) in GIS containing 2 mM CaCl 2 on ice then gently triturated into individual myocytes using a fire-polished Pasteur pipette.
Using the conventional whole-cell patch clamp configuration, K ATP currents were recorded in freshly isolated cerebellar arterial myocyte at room temperature (Wellman et al. 1999) . The bath solution contained 134 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES (pH 7.4). The "140 mM K + " bath solution was made by isoosmotic replacement of NaCl with KCl. The pipette solution contained 107 mM KCl, 1.0 mM MgCl 2 , 1.9 mM CaCl 2 , 10 mM HEPES, 5 mM EGTA, and 25 mM KOH (pH 7.2 adjusted with KOH, free Ca 2+~1 00 nM). On the day of the experiment, 0.1 mM Na 2 ATP, 0.1 mM NaADP, and 0.1 mM LiGTP were freshly added into an aliquot of pipette solution. K ATP currents were recorded at −60 mV. After a stable baseline was obtained, the extracellular solution was changed from "6 mM K + " bath solution to "140 mM K + " bath solution. PACAP was treated by superfusation into the bath in the presence of 140 mM K + . Transient outward BK currents were measured using the perforated whole-cell patch-clamp technique at room temperature (Wellman et al. 2002; Koide et al. 2011) . The bath solution contained 134 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES (pH 7.4). Patch pipettes (8-10 MΩ) were filled with a pipette solution that contained 110 mM K + -aspartate, 30 mM KCl, 10 mM NaCl, 1 mM MgCl 2 , 10 mM HEPES, 0.05 mM EGTA, and 0.2 mM amphotericin B (pH 7.2). Transient outward currents were recorded at −40 mV. PACAP was treated by bath superfusation. Recordings were analyzed using Mini Analysis 6.0.3 software (Synaptosoft, Inc., Decatur, GA, USA) to determine transient BK current amplitude, frequency, rise time (time from 10 to 90 % of the peak), decay time (time from 90 to 37 % of the peak), and halfwidth (time at 50 % of the peak). The threshold for current peak detection was set at two and half times the single channel amplitude of the BK channel: 5.0 pA at −40 mV (Perez et al. 2001 ).
Diameter Measurements of Isolated Cerebellar Arteries
Superior cerebellar arteries were cannulated onto glass micropipettes mounted in 5 mL myograph chamber, and the intravascular pressure was increased using a servo controller and a peristaltic pump (Living Systems Instruments, St. Albans, VT, USA) as previously described (Ishiguro et al. 2002; Nystoriak et al. 2011; Koide et al. 2012) . The arteries were continuously superfused with aCSF warmed at 37°C. Luminal diameter was measured and recorded using video edge detection (Living Systems Instrumentation, St Albans, VT, USA) and WinDaq data acquisition software (Dataq Instruments; Akron, OH, USA). Following a 30-min equilibration period at 20 mmHg, arteries were briefly exposed to 60 mM KClaCSF (<2 min; iso-osmotic replacement of NaCl with KCl) to test their viability. Only arteries that exhibited constriction of 50 % or more to 60 mM KCl-aCSF were included for study. Following an additional 30 min, intraluminal pressure was increased to 60 mmHg. Over the course of approximately 1 h, arteries constricted to the increase in intravascular pressure, i.e., developed pressure-induced myogenic tone. Once arterial diameter was stabilized at 60 mmHg, PACAP (3 nM) was superfused into the chamber in the absence and presence of K + channel blocker(s). Percent constriction in response to elevation of intravascular pressure was determined using the following equation: [(DP−DA)/DP]×100, where DP = the (passive) diameter of the artery in Ca 2+ -free aCSF containing the vasodilators diltiazem (100 μM) and forskolin (1 μM) and DA = the (active) diameter of the artery in Ca 2+ -containing aCSF. Dilation responses to PACAP are expressed as a reduction in arterial constriction using the following equation: % dilation = [(DV−DA)/(DP−DA)]×100, where DV = arterial diameter in the presence of vasodilator, DA = the active diameter of the artery prior to addition of vasodilator, and DP = the passive diameter of the artery. All aliquots of compounds used in the study were diluted to their final concentrations immediately before use and were administered to arteries by bath superfusion (5 mL/min flow rate) for a minimum of 10 min. Chemicals PACAP was obtained from American Peptide Company (Sunnyvale, CA, USA). All other compounds were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Statistics
Data are expressed as mean ± SEM. Comparisons between multiple groups were analyzed by one-way ANOVA followed by post hoc comparison of means using Tukey test. Student's paired t test was used to compare data between two groups. Statistical significance was considered at p<0.05.
Results
PACAP Activates K ATP Channels in Freshly Isolated Rat Cerebellar Artery Myocytes
Several endogenous vasodilators (e.g., CGRP, adenosine) linked to increased adenylyl cyclase activity have been shown to activate K ATP channels in arterial smooth muscle cells (Nelson et al. 1990; Quayle et al. 1994; Nelson 1995a, 1995b; Wellman et al. 1998) . To examine whether PACAP can increase K ATP channel activity in freshly isolated cerebellar artery myocytes, membrane K + currents were measured by patch clamp electrophysiology. Here, recording conditions using the conventional whole-cell configuration were designed to optimize K ATP currents and minimize BK and voltage-dependent K + (K V ) channel activity (e.g., 0.1 mM ATP, 0.1 mM ADP, and 5 mM EGTA in intracellular pipette solution; holding potential of −60 mV) (Wellman et al. 1998) . In symmetrical (intracellular and extracellular) 140 mM K + , the K + equilibrium potential (E K ) predicted by the Nerst equation is 0 mV. Thus, at a holding potential negative to E K , e.g., −60 mV, K ATP channel activation will cause K + ions to move into the cell creating an inward electrical current (Quayle et al. 1994; Kleppisch and Nelson 1995b; Wellman et al. 1998) . As shown in Fig. 1a , treatment of a cerebral artery myocyte with the synthetic K ATP channel opener, pinacidil (10 μM), caused a significant increase in inward K + current that was inhibited by the K ATP channel blocker, glibenclamide (10 μM). Using similar recording conditions, PACAP (3 nM) treatment also caused an increase in inward K + current (Fig. 1b) . This data suggests that PACAP can activate K ATP channels in rat cerebellar artery myocytes.
PACAP Increases the Frequency of Transient Outward BK Currents in Rat Cerebellar Artery Myocytes
An increase in the frequency of smooth muscle transient outward BK currents represents another potential mechanism involved in PACAP-induced cerebral artery dilation. Transient BK currents represent the coordinated opening of up to 100 individual BK channels in regions of the cell membrane (≈1 % of the total cell surface area) exposed to brief local increases in Ca 2+ caused by Ca 2+ sparks (Wellman and Nelson 2003) . Treatment of vascular smooth muscle cells with either a cAMP analog, an adenylyl cyclase activator (e.g., forskolin), or endogenous vasodilators that elevate intracellular cAMP levels causes an increase in the frequency of Ca 2+ spark-induced transient BK currents (Porter et al. 1998; Wellman et al. 2001) . Considering that PACAP can potently increase intracellular cAMP levels, activation of the Ca 2+ spark/transient BK current pathway may also contribute to PACAP-induced cerebral artery dilation. To examine this hypothesis, we directly measured transient BK currents in freshly isolated cerebellar artery myocytes using the wholecell perforated patch configuration of the patch clamp technique. In this experimental series, cells were held at the physiological membrane potential of −40 mV in an extracellular (bath) solution containing 6 mM K + . Spontaneous transient outward BK currents were observed in these cells and PACAP (3 nM) significantly increased the frequency of these events by approximately 50 % (from 1.38±0.47 to 2.02± 0.51 Hz; n=6 cells from three animals, Fig. 2a, b) . Although PACAP markedly increased the transient BK current frequency, the amplitude of these events was not dramatically altered by PACAP treatment (before treatment 14.71±2.11 pA, after PACAP treatment 17.49±2.98 pA, Fig. 2c) The above studies indicate that PACAP can increase the activity of both BK and K ATP channels in freshly isolated cerebellar artery myocytes. Next, the functional contribution of these K + channels in PACAP-induced dilation was examined in isolated and pressurized rat superior cerebellar arteries. At a physiological intravascular pressure of 60 mmHg, arteries superfused with aCSF developed pressure-induced constriction (myogenic tone) representing a 23.0±1.3 % decrease in diameter (n=19 from 19 animals). At 60 mmHg, the average diameter of cerebellar arteries in aCSF with myogenic tone was 191.1±7.5 μm compared to a fully dilated diameter of 247.2±7.5 μm obtained in Ca 2+ -free aCSF containing diltiazem (100 μM, a voltage-dependent Ca 2+ channel blocker) and forskolin (1 μM). PACAP (3 nM) caused significant dilation (52.2±10.7 % of maximal dilation), increasing the average arterial diameter from 189.8±9.1 to 220.8±14.0 μm (n=4 Fig. 1 K ATP channel currents in rat cerebellar artery myocytes. a K ATP current measurement obtained from an isolated cerebellar artery myocyte using the conventional whole-cell configuration of the patch clamp technique. The synthetic K ATP channel opener, pinacidil (10 μM), caused an increase in inward current that was inhibited by the K ATP channel blocker, glibenclamide (10 μM). b Original recording of PACAP treatment on inward K + current using the same recording conditions described in a. PACAP (3 nM) increased inward K + current, suggesting increased K ATP current from four animals, Fig. 3a, e) . To examine whether K ATP channel activation (shown in Fig. 1b) contributes to PACAPinduced cerebellar artery dilation, arteries were treated with the K ATP channel blocker, glibenclamide (10 μM). Glibenclamide treatment alone did not change arterial diameter (187.0±14.7 and 185.8±16.4 μm, in the absence and presence of glibenclamide, respectively, n=4 from four animals), suggesting minimal basal K ATP channel activity in these arteries. However, in the presence of glibenclamide, the PACAP-induced dilations were significantly attenuated (approximately 50 % of maximal dilation with PACAP alone vs 22.6 ± 11.8 % of maximal dilation in PACAP + glibenclamide; n=4 from four animals, Fig. 3b ). This data indicates that PACAP-induced vasodilation is partially caused by K ATP channel activation.
We next examined if activation of the Ca 2+ spark/transient BK current pathway also plays a role in PACAP-induced cerebellar artery dilation. To inhibit this pathway, arteries were treated with the BK channel blocker, paxilline (1 μM), which alone constricted arteries in aCSF from 204.0±13.4 to 174.4± 14.7 μm, an approximate 15 % decrease in diameter on top of myogenic tone (Fig. 3c , note paxilline-induced vasoconstriction before PACAP application; fully dilated diameter 262.6± 11.1 μm, n=7 from seven animals). This paxilline-induced vasoconstriction is consistent with previous studies demonstrating that the Ca 2+ spark/transient BK current pathway plays an important negative-feedback role in the regulation of cerebral artery myogenic tone (Nelson et al. 1995; Koide et al. 2011; Nystoriak et al. 2014) . The PACAP-induced vasodilation was significantly attenuated in the presence of paxilline (approximately 50 % maximal dilation with PACAP alone vs 14.8±2.6 % of maximal dilation in PACAP + paxilline; n=7 from seven animals), suggesting that the Ca 2+ spark/transient BK current pathway is also involved in PACAP-induced dilation (Fig. 3c, e) . Thus, when applied separately, blockers of K ATP channels (glibenclamide) and BK channels (paxilline) both decreased PACAP-induced dilations by approximately 50 %. Interestingly, the combined treatment of arteries with both glibenclamide and paxilline abolished PACAP-induced cerebellar artery dilation. In the presence of glibenclamide and paxilline, arterial diameter before and after PACAP treatment was 174.0±21.9 and 163.5 ± 23.7 μm, respectively (n = 4 from four animals, Fig. 3d, e) . In summary, these data indicate that PACAP causes cerebellar artery dilation through activation of both K ATP and BK channels.
Discussion
Here we demonstrate that two distinct mechanisms contribute to PACAP-induced cerebellar artery dilation: activation of K ATP channels and BK channels. The involvement of smooth muscle K ATP and BK channels in cerebral artery dilations caused by PACAP (depicted in Fig. 4 ) is supported by our following observations: (1) PACAP increased K ATP channel activity in isolated rat cerebellar artery myocytes, (2) PACAP also increased the frequency of cerebral artery smooth muscle transient BK currents, (3) individual application of either the K ATP channel blocker (glibenclamide) or the BK channel blocker (paxilline) significantly attenuated PACAP-induced cerebral artery dilation (~50 % attenuation in the presence of either blocker), and (4) the combined treatment of arteries with glibenclamide and paxilline abolished PACAP-induced dilation of pressurized rat cerebellar arteries.
In vascular smooth muscle, functional K ATP channels are thought to be composed of four Kir 6.1 pore-forming subunits encoded by the gene KCNJ8 and four SUR2B accessory subunits encoded by the gene ABCC9 (Flagg et al. 2010) . K ATP channels of arterial myocytes are activated by a variety of endogenous vasodilators such as CGRP (Nelson et al. 1990; Quayle et al. 1994; Nelson 1995a, 1995b; Wellman et al. 1998 ) as well as cAMP analogs and cell dialysis with the catalytic subunit of PKA (Quayle et al. 1994; Wellman et al. 1998) . PKA-mediated phosphorylation of serine and threonine residues within the nucleotide binding folds of SUR2B subunits is thought to promote ADP binding to increase channel activity (Quinn et al. 2004; Shi et al. 2007; Flagg et al. 2010) . In this study, we demonstrate that PACAP, another endogenous vasodilator known to stimulate adenylyl cyclase activity (Tong et al. 1993; Vaudry et al. 2009 ), can activate K ATP channels in rat cerebral artery smooth muscle. As shown in Fig. 1 , activation of K ATP currents by pinacidil and PACAP evoked inward membrane currents at −60 mV using intracellular and extracellular solutions that both contained 140 mM K + . However, with physiological K + concentrations (e.g., extracellular K + ≈5.4 mM; intracellular K + ≈ 140 mM), K ATP channel activation causes outward membrane currents in isolated arterial smooth muscle cells and membrane potential hyperpolarization and vasodilation of intact arteries (Standen et al. 1989; Masuzawa et al. 1990; Quayle et al. 1994; Kleppisch and Nelson 1995b; Nelson and Quayle 1995; Bruch et al. 1997 Bruch et al. , 1998 . Consistent with our electrophysiological recordings, PACAP-induced cerebellar artery dilation was significantly attenuated by the K ATP channel blocker glibenclamide (Fig. 3) . Together, these data indicate that K ATP channel activation contributes to PACAP-induced vasodilation in rat cerebellar arteries likely via activation of the cAMP/ PKA pathway.
In addition to activation of K ATP channels, increased intracellular cAMP and PKA activation can also enhance the Ca 2+ spark/transient BK current signaling pathway to promote cerebral artery dilation (Porter et al. 1998; Wellman et al. 2001 ). Our data now shows that PACAP increases the frequency of transient BK currents in rat cerebellar artery myocytes (Fig. 2) and that BK channel activity is involved in PACAP-induced cerebral artery dilation (Fig. 3) -spark induced transient BK currents. Secondly, phosphorylation of phospholamban (PLB) can also contribute to PKA-mediated cerebral artery dilation (Simmerman and Jones 1998; Wellman et al. 2001) . Phospholamban is a regulatory protein that when bound to SR Ca 2+ -ATPase (SERCA) causes a decrease in SERCA activity and reduced filling of the SR with Ca 2+ . Phosphorylation by PKA causes PLB to dissociate from SERCA, leading to disinhibition of SERCA activity and elevation of SR Ca 2+ load (Simmerman and Jones 1998; Wellman et al. 2001 ) that can increase Ca 2+ spark/BK current frequency and amplitude (ZhuGe et al. 1999) . Lastly, PKA can increase BK channel activity via direct channel phosphorylation (Minami et al. 1993; Perez and Toro 1994; Porter et al. 1998) . Phosphorylation of BK channels by PKA causes a leftward-shift in the voltageactivation relationship (toward more negative membrane potential) without changing single channel conductance (Perez and Toro 1994) . Further, it has been suggested that cAMP can directly increase the open-state probability of BK channels based on the observation of increased single BK channel activity by application of cAMP to the intracellular side of excised membrane patches (Minami et al. 1993) . A direct cAMP/PKA-mediated increase in BK channel activity would likely cause an increase in the amplitude of transient BK currents without altering Ca 2+ spark frequency. In the present study, we demonstrate that PACAP increases the frequency, but not amplitude, of transient BK currents in isolated rat cerebellar artery myocytes. This observation is consistent with PACAP causing an increase in Ca 2+ spark frequency rather than directly altering the voltage-sensitivity of plasma membrane BK channels. Future studies are required to confirm the involvement of the cAMP/PKA pathway in PACAPinduced cerebral artery dilation, as well as the specific proteins involved in the observed increase in Ca 2+ spark/ transient BK current frequency. However, we clearly demonstrate the functional importance of the Ca 2+ spark/BK channel pathway in PACAP-induced cerebellar artery dilation. As illustrated in Fig. 3 , the BK channel blocker, paxilline, attenuated PACAP-induced vasodilation by approximately~50 %. Furthermore, the combined treatment of cerebral arteries with paxilline and the K ATP channel blocker, glibenclamide, completely inhibited cerebral artery responses to PACAP. These data suggested that two pathways, activation of K ATP and BK channels, are independent and both play an important role in PACAPinduced cerebellar artery dilation.
In summary, here we demonstrate that two distinct cell signaling mechanisms contribute to PACAP-induced dilation in rat cerebellar arteries: K ATP channel activation and enhanced BK channel activity. Both mechanisms likely involve activation of the cAMP/PKA pathway; however, further studies are needed to determine additional details of the intracellular signaling pathways linking PACAP receptor activation to these ion channels. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 31:1411-1417
